MENU
ANTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AN2 Therapeutics (ANTX) Earnings Date & Reports
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more
Industry: #Managed Health Care
A.I. Advisor
published Earnings
ANTX is expected to report earnings to rise 22.22% to -21 cents per share on November 05
Q3'26
Est.
$-0.22
Q2'26
Beat
by $0.05
Q1'26
Missed
by $0.06
Q4'25
Missed
by $0.07
Q3'25
Est.
$-0.31
The last earnings report on August 11 showed earnings per share of -18 cents, beating the estimate of -23 cents. With 190.79K shares outstanding, the current market capitalization sits at 127.17M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
What is a covered call?
What are My SIMPLE IRA Investment Options?
What Is an Initial Public Offering (IPO)?
Credit Cracks: How to Position Your Bond ETF Portfolio as Money Rushes Out of Corporate Debt
How to Trade Energy Stocks During War: AI Robot with 62% Win Rate & +60% Return Crushes SPY While Oil Surges to $150/bbl
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
Managed Health Care
Address
1300 El Camino Real
Phone
+1 650 331-9090
Employees
21
Web
https://www.an2therapeutics.com